
Ask a doctor about a prescription for DONEPEZIL Aurovitas Spain 5 mg ORALLY DISINTEGRATING TABLETS
Package Leaflet: Information for the User
Donepezil Flas Aurovitas Spain 5 mg Orodispersible Tablets EFG
Donepezil Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Donepezil Flas Aurovitas Spain belongs to a group of medicines called acetylcholinesterase inhibitors. Donepezil increases the levels in the brain of a substance related to memory (acetylcholine), by reducing the speed of breakdown of this substance.
It is used to treat the symptoms of dementia in people diagnosed with mild to moderately severe Alzheimer's disease. The symptoms include increased memory loss, confusion, and behavioral changes. As a result, patients with Alzheimer's disease find it increasingly difficult to carry out their normal daily activities.
Donepezil should only be used in adult patients.
Do not take Donepezil Flas Aurovitas Spain
Warnings and precautions
Consult your doctor or pharmacist before starting to take Donepezil Flas Aurovitas Spain if you have or have had:
In addition, tell your doctor if you are pregnant, or think you may be pregnant.
Donepezil may be used in patients with mild to moderate kidney or liver disease. Inform your doctor first if you have kidney or liver disease. Patients with severe liver disease should not take this medicine. In unexplained cases of altered liver function, your doctor may consider discontinuing treatment with donepezil.
Tell your doctor or pharmacist the name of your caregiver. Your caregiver will help you take your medicine as prescribed.
Use in children and adolescents
Donepezil is not recommended for use in children and adolescents.
Other medicines and Donepezil Flas Aurovitas Spain
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes medicines that your doctor has not prescribed but that you have bought yourself. It also applies to medicines that you might take in the future if you continue to take donepezil. This is because these medicines may weaken or strengthen the effects of donepezil.
In particular, it is important that you tell your doctor if you are taking any of the following medicines:
If you are going to undergo an operation that requires general anesthesia, you must inform your doctor and anesthetist that you are taking donepezil. This is because your medicine may affect the amount of anesthetic needed.
Taking Donepezil Flas Aurovitas Spain with food, drinks, and alcohol
Food does not affect the effect of donepezil.
You should avoid taking alcohol while being treated with donepezil, as it may reduce the effect of this medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
This medicine should not be used during pregnancy unless your doctor decides that it is clearly necessary.
Donepezil should not be used in women who are breastfeeding.
Driving and using machines
Donepezil and the disease may affect your ability to drive or use machines, and you should not carry out these activities unless your doctor tells you it is safe to do so.
The medicine may cause fatigue, dizziness, and muscle cramps. If you experience these effects, do not drive or use machines.
Donepezil Flas Aurovitas Spain contains sodium, lactose, and aspartame
This medicine contains less than 23 mg of sodium (1 mmol) per orodispersible tablet; this is essentially "sodium-free".
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
This medicine contains 124.7 mg of aspartame in each orodispersible tablet.
Aspartame is a source of phenylalanine, which may be harmful in people with phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.
How much Donepezil Flas Aurovitas Spain should you take? Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Take the orodispersible tablet as follows:
The tablets are taken orally.
To avoid crushing the orodispersible tablet, do not press the blister (Figure A).

Fig. A
Each blister pack contains six blisters, which are separated by perforations. Separate a blister by following the perforated lines (Figure 1).

Fig. 1
Carefully remove the foil, starting from the corner marked with an arrow (Figures 2 and 3).

Fig. 2

Fig. 3
Remove the orodispersible tablet with dry hands and place it on the tongue (Figure 4).

Fig. 4
It will dissolve quickly and can be swallowed with or without water, as you prefer.
Initially, the recommended dose is 5 mg (one white tablet) each night before bedtime.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take donepezil in the morning.
After one month of treatment, your doctor may indicate that you take 10 mg (one yellow tablet) each night before bedtime.
The dose of the tablet you take may change depending on how long you have been taking the medicine and what your doctor recommends. The maximum recommended dose is 10 mg each night.
Always follow the advice of your doctor or pharmacist on how and when to take the medicine. Do not change the dose without consulting your doctor.
How to take Donepezil Flas Aurovitas Spain
The tablet should be placed on your tongue and allowed to dissolve before swallowing, with or without water, as you prefer.
Use in children and adolescents
Donepezil is not recommended for use in children and adolescents (under 18 years of age).
Duration of treatment with Donepezil Flas Aurovitas Spain
Your doctor or pharmacist will advise you on how long you should continue taking your tablets. You will need to visit your doctor regularly to review your treatment and assess your symptoms.
If you take more Donepezil Flas Aurovitas Spain than you should
In case of overdose or accidental ingestion, go to a Medical Center or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested. It is recommended to carry the package and the package leaflet of the medicine.
The symptoms of overdose may include nausea, vomiting, salivation, sweating, slow heartbeat, low blood pressure (dizziness or vertigo when standing up), difficulty breathing, loss of consciousness, and epileptic seizures or convulsions.
If you forget to take Donepezil Flas Aurovitas Spain
If you forget to take your medicine, take the next dose at the usual time.
Do not take a double dose to make up for the missed tablet.
If you forget to take the medicine for more than one week, call your doctor before taking the medicine again.
If you stop taking Donepezil Flas Aurovitas Spain
Do not stop taking donepezil unless your doctor tells you to. If you stop taking donepezil, the benefits of treatment will gradually disappear.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported by people taking donepezil.
Contact your doctor if you have any of these side effects during treatment with donepezil.
Serious side effects:
You should tell your doctor immediately if you notice any of the following serious side effects. You may need urgent medical treatment.
Other side effects
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from the available data):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.
Store in the original blister pack to protect from moisture.
This medicine does not require any special storage temperature.
Medicines should not be disposed of via wastewater or household waste. Return the packages and medicines you no longer need to the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medicines that are no longer needed. This will help protect the environment.
Composition of Donepezil Flas Aurovitas Spain
Appearance of the product and pack contents
The Donepezil Flas Aurovitas Spain 5 mg orodispersible tablets are white to off-white, round, flat, with beveled edges, engraved with a '5' on one face.
Pack sizes:
Blister packs of 7, 28, 30, 50, 56, 60, 98, and 120 orodispersible tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer
Genepharm S.A.
18th km Marathonos Avenue
Pallini 15351, Attiki
Greece
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany: Donepezilhydrochlorid PUREN 5 mg Schmelztabletten
Spain: Donepezilo Flas Aurovitas Spain 5 mg orodispersible tablets EFG
Portugal: Donepezilo Aurovitas
Date of last revision of this leaflet:December 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DONEPEZIL Aurovitas Spain 5 mg ORALLY DISINTEGRATING TABLETS – subject to medical assessment and local rules.